Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Bereznicki LRE"'
Publikováno v:
Clinical Interventions in Aging, Vol Volume 12, Pp 1573-1578 (2017)
Justin M Cousins, Luke RE Bereznicki, Nick B Cooling, Gregory M Peterson School of Medicine, Faculty of Health, University of Tasmania, Hobart, TAS, Australia Objective: The aim of this study was to identify factors influencing the prescribing of psy
Externí odkaz:
https://doaj.org/article/74bf53c262b446baa27b04635a042188
Autor:
Stafford, L, Van Tienen, EC, Peterson, GM, Bereznicki, LRE, Jackson, SL, Bajorek, BV, Mullan, JR, DeBoos, IM
What is Known and Objective: Warfarin is recognized as a high-risk medication for adverse events, and the risks are particularly heightened in the period immediately following a patient's discharge from hospital. This qualitative study aimed to explo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::ad364c2522e79886cacbf06c68e5e665
https://hdl.handle.net/10453/18666
https://hdl.handle.net/10453/18666
Autor:
Zaidi AS; School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, Australia., Peterson GM; School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, Australia Faculty of Health, University of Canberra, Canberra, ACT, Australia., Bereznicki LRE; School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, Australia., Curtain CM; School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, Australia., Salahudeen MS; School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart 7005, Australia.
Publikováno v:
Therapeutic advances in drug safety [Ther Adv Drug Saf] 2022 Mar 11; Vol. 13, pp. 20420986221080796. Date of Electronic Publication: 2022 Mar 11 (Print Publication: 2022).
Autor:
Ali S; School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, 7005, Australia., Salahudeen MS; School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, 7005, Australia., Bereznicki LRE; School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, 7005, Australia., Curtain CM; School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, 7005, Australia.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Oct; Vol. 87 (10), pp. 3672-3689. Date of Electronic Publication: 2021 Apr 20.
Autor:
Zaidi AS; School of Pharmacy and Pharmacology, University of Tasmania, Hobart, Australia., Peterson GM; School of Pharmacy and Pharmacology, University of Tasmania, Hobart, Australia.; Faculty of Health, University of Canberra, Australia., Bereznicki LRE; School of Pharmacy and Pharmacology, University of Tasmania, Hobart, Australia., Curtain CM; School of Pharmacy and Pharmacology, University of Tasmania, Hobart, Australia., Salahudeen M; School of Pharmacy and Pharmacology, University of Tasmania, Hobart, Australia.
Publikováno v:
The Annals of pharmacotherapy [Ann Pharmacother] 2021 Apr; Vol. 55 (4), pp. 530-542. Date of Electronic Publication: 2020 Aug 10.
Autor:
Wright CM; 1 School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Australia.; 2 Health Systems and Health Economics, Faculty of Health Sciences, School of Public Health, Curtin University, Perth, Western Australia., Bezabhe W; 1 School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Australia., Fitton JH; 3 Marinova, Hobart, Australia., Stringer DN; 3 Marinova, Hobart, Australia., Bereznicki LRE; 1 School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Australia., Peterson GM; 1 School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Australia.
Publikováno v:
Journal of alternative and complementary medicine (New York, N.Y.) [J Altern Complement Med] 2019 Mar; Vol. 25 (3), pp. 346-352. Date of Electronic Publication: 2018 Oct 12.
Autor:
Obamiro KO; Pharmacy, School of Medicine, University of Tasmania, Tasmania, Australia., Chalmers L; Pharmacy, School of Medicine, University of Tasmania, Tasmania, Australia., Lee K; Pharmacy, School of Medicine, University of Tasmania, Tasmania, Australia., Bereznicki BJ; Pharmacy, School of Medicine, University of Tasmania, Tasmania, Australia., Bereznicki LRE; Pharmacy, School of Medicine, University of Tasmania, Tasmania, Australia.
Publikováno v:
International journal of clinical practice [Int J Clin Pract] 2018 Mar; Vol. 72 (3), pp. e13072. Date of Electronic Publication: 2018 Feb 19.
Autor:
Rolls CA; Pharmacy, School of Medicine, University of Tasmania, Hobart, Tas, Australia., Obamiro KO; Pharmacy, School of Medicine, University of Tasmania, Hobart, Tas, Australia., Chalmers L; Pharmacy, School of Medicine, University of Tasmania, Hobart, Tas, Australia., Bereznicki LRE; Pharmacy, School of Medicine, University of Tasmania, Hobart, Tas, Australia.
Publikováno v:
Cardiovascular therapeutics [Cardiovasc Ther] 2017 Dec; Vol. 35 (6). Date of Electronic Publication: 2017 Sep 25.
Autor:
Bista D; 1 Pharmacy, School of Medicine, University of Tasmania, Hobart, Tasmania, Australia., Chalmers L; 1 Pharmacy, School of Medicine, University of Tasmania, Hobart, Tasmania, Australia., Peterson GM; 2 Health Services Innovation (Tasmania), School of Medicine, University of Tasmania, Hobart, Tasmania, Australia., Bereznicki LRE; 1 Pharmacy, School of Medicine, University of Tasmania, Hobart, Tasmania, Australia.
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2017 Sep; Vol. 23 (6), pp. 573-578. Date of Electronic Publication: 2016 Apr 12.